Pharmaceuticals news FT.com

Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs

Danish company has had some poor results for new drugs designed to replace treatments when they go off patent

May 14, 2025 - 14:18
 0
Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs
Danish company has had some poor results for new drugs designed to replace treatments when they go off patent
Read More

Tags:

Previous Article

AbbVie pays ADARx $335M cash for next-gen siRNA options

Next Article

STAT+: Pharmalittle: We’re reading about Trump’s threat to pharma, biotechs shif...

Related Posts

Trump’s drug price treatment is harsh but justified

Trump’s drug price treatment is harsh but justified

May 13, 2025  0

Trump vows to lower drug prices in the US by up to 80%

Trump vows to lower drug prices in the US by up to 80%

May 12, 2025  0

Roche to spend $50bn on US manufacturing and R&D

Roche to spend $50bn on US manufacturing and R&D

May 12, 2025  0